Drug
Apremilast
Apremilast: highest development phase Phase 3, developed by Amgen. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Apremilast NCT05767047 | Phase 3 | Behçet's Disease |
| Apremilast XR NCT07908641 | Phase 1 | Psoriasis |
Latest
No recent events.
Follow Apremilast on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.